SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000830656-02-000013
Filing Date
2002-05-14
Accepted
2002-05-14 13:53:05
Documents
14
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE THREE MONTHS ENDED MARCH 31, 2002 form10-q1_2002.htm 10-Q 55779
2 GRAPHIC balance_sheets.gif GRAPHIC 17482
3 GRAPHIC cash_flow.gif GRAPHIC 20587
4 GRAPHIC eps.gif GRAPHIC 6287
5 GRAPHIC exhibit_listing.gif GRAPHIC 70407
6 GRAPHIC income_statement.gif GRAPHIC 13022
7 GRAPHIC inventories.gif GRAPHIC 3511
8 GRAPHIC logo.gif GRAPHIC 2834
9 GRAPHIC segment_assets.gif GRAPHIC 4600
10 GRAPHIC segment_operatingloss.gif GRAPHIC 4235
11 GRAPHIC segment_revenue.gif GRAPHIC 4135
12 EXHIBIT 10.32 director_compensation.htm EX-10 2230
13 EXHIBIT 10.33 source_lease.htm EX-10 13874
14 GRAPHIC rent_table.gif GRAPHIC 3448
  Complete submission text file 0000830656-02-000013.txt   225386
Mailing Address 375 WEST ST WEST BRIDGEWATER MA 02379
Business Address 375 WEST STREET WEST BRIDGEWATER MA 02379 5085801900
BOSTON BIOMEDICA INC (Filer) CIK: 0000830656 (see all company filings)

IRS No.: 042652826 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21615 | Film No.: 02645840
SIC: 2835 In Vitro & In Vivo Diagnostic Substances